|
業務類別
|
-- |
|
業務概覽
|
Healios KK is involved in development and sales of opthalmological surgery adjuvants and research, development and manufacture of cell therapy products and regenerative medicine products. The company is developing treatments for age-related macular degeneration and organ anlage transplantation therapy. |
| 公司地址
| World Trade Center Bldg. 15th Floor, 2-4-1 Hamamatsucho, Minato-ku, Tokyo, JPN, 105-6115 |
| 電話號碼
| -- |
| 傳真號碼
| -- |
| 公司網頁
| https://www.healios.co.jp |
| 員工數量
| 108 |
| Dr. Hardy TS Kagimoto, M.D. |
Chairman of the Board and Chief Executive Officer |
-- |
28/03/2022 |
| Mr. Richard P. Kincaid |
Director and Chief Financial Officer; President of Healios NA, Inc. |
-- |
28/03/2022 |
|
|
| Mr. Cam S. Gallagher |
Director |
28/03/2022 |
| Mr. Glenn Gormley |
Director |
28/03/2022 |
| Dr. Hardy TS Kagimoto, M.D. |
Chairman of the Board and Chief Executive Officer |
28/03/2022 |
| Mr. Yoshinari Matsuda |
Director |
28/03/2022 |
| Mr. Seigo Kashii |
Director |
28/03/2022 |
| Mr. Richard P. Kincaid |
Director and Chief Financial Officer; President of Healios NA, Inc. |
28/03/2022 |
| Ms. Yuko Yogo |
Director |
28/03/2022 |
| Mr. Toichi Takenaka |
Director |
28/03/2022 |
| Mr. Paul Bresge |
Director |
28/03/2022 |
| Mr. James Paradise |
Director |
28/03/2022 |
|
|
|
|
